Item 1A. Risk Factors
3K characters. Original on sec.gov · Markdown
Item 1A. Risk Factors
| Risk Factors | | |
There were no material changes to the risk factors disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025.
| Item 2. | ||
| Unregistered Sales of Equity Securities and Use of Proceeds |
Purchases of our equity securities during the quarter ended June 30, 2026 are summarized below.
| Period | Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased As Part of Publicly Announced Plans or Programs | Maximum Number of Shares That May Yet Be Purchased Under the Plans or Programs****1 | ||||||||||||||||||||||||||||
| April 1 - April 30 | 712,388 | $ | 280.75 | 712,388 | 4,056,099 | |||||||||||||||||||||||||||
| May 1 - May 31 | 192,042 | $ | 261.66 | 192,042 | 3,864,057 | |||||||||||||||||||||||||||
| June 1 - June 30 | 0 | $ | 0.00 | 0 | 3,864,057 | |||||||||||||||||||||||||||
| Total | 904,430 | $ | 276.69 | 904,430 |
1In February 2017, our Board of Directors authorized us to purchase up to 10,000,000 shares of our common stock. As of June 30, 2026, there were 3,864,057 shares remaining under this authorization. Depending upon market, business, legal and other conditions, we may purchase shares from time to time through the open market (including plans designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934) and/or through privately negotiated transactions. The authorization has no time limit, does not obligate us to purchase any specific number of shares and may be suspended or discontinued at any time.
We did not have any unregistered sales of equity securities during the second quarter of 2026.
| Item 4. | ||
| Mine Safety Disclosures |
The information concerning mine safety violations or other regulatory matters required by Section 1503(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 104 of Regulation S-K is included in Exhibit 95 of this report.
Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information